Concepedia

Author

Alvydas Mikulskis

Biogen (United States)

Also Known As

A Mikul'skis, A Mikulskis, A V Mikulskis, ALVYDAS MIKULSKIS, Alvydas Mikulskis, Alvydas V. Mikulskis

42

Publications

5.2K

Citations

21

H-Index

63

Concepts

All Affiliations

Biogen (United States)PerkinElmer (United States)Pfizer (United States)Bristol-Myers Squibb (United States)AbbVie (United States)
AM

About

Alvydas Mikulskis is an author at Biogen (United States) specializing in medicine, immunology, and allergy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

3.5K

2

Allergy

4

4

238

3

Natural Sciences

3

3

166

4

Engineering

2

2

61

5

Social Sciences

1

1

10

Alvydas Mikulskis

×

21

Publications

4.3K

Citations

18

H-Index

YearCitations

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Jeff Sevigny, Ping Chiao, Thierry Bussière,

Nature

2016

3K

First‐in‐human, double‐blind, placebo‐controlled, single‐dose escalation study of aducanumab (BIIB037) in mild‐to‐moderate Alzheimer's disease

J L Ferrero, Leslie Williams, Heather Stella,

Alzheimer s & Dementia Translational Research & Clinical Interventions

2016

176

Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment

Shorena Janelidze, Josef Pannee, Alvydas Mikulskis,

JAMA Neurology

2017

139

High-Resolution Serum Proteomic Profiling of Alzheimer Disease Samples Reveals Disease-Specific, Carrier-Protein–Bound Mass Signatures

Mary F. Lopez, Alvydas Mikulskis, Scott Kuzdzal,

Clinical Chemistry

2005

138

A Novel, High-Throughput Workflow for Discovery and Identification of Serum Carrier Protein-Bound Peptide Biomarker Candidates in Ovarian Cancer Samples

Mary F. Lopez, Alvydas Mikulskis, Scott Kuzdzal,

Clinical Chemistry

2007

112

Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies

Sreeja Gopal, Alvydas Mikulskis, Ralf Gold,

Multiple Sclerosis Journal

2017

100

Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development

Alvydas Mikulskis, Dave Yeung, Meena Subramanyam,

Journal of Immunological Methods

2010

93

Regulation of the <i>Yersinia enterocolitica</i> enterotoxin Yst gene. Influence of growth phase, temperature, osmolarity, pH and bacterial host factors

Alvydas Mikulskis, Isabelle Delor, Vinh Ha Thi,

Molecular Microbiology

1994

76

2013 White Paper on Recent Issues in Bioanalysis: ‘ <i>Hybrid</i> ’ – The Best of LBA and LCMS

Lauren Stevenson, Fabio Garofolo, Binodh DeSilva,

Bioanalysis

2013

74

Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum

David T Yeung, Shawn Ciotti, Shobha Purushothama,

Journal of Immunological Methods

2016

67

Page 1